Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Recipients of Myelotoxic Chemotherapy Have Increased Prevalence of Clonal Hematopoiesis of Indeterminate Potential (CHIP) with a Typical Distribution of Chip-Associated Mutations

Adam J Olszewski, MD, Anna Dorota Chorzalska, PhD, Annette S. Kim, MD PhD, Peter J. Quesenberry, MD, Mary L Lopresti, DO, Mary Anne Fenton, MD, John L. Reagan, MD, James Butera, MD, Ilyas Sahin, MD, Celine Hamel, CRA, Jordan Robison, CRA, Max Petersen, Patrycja Dubielecka, PhD

Blood (2018) 132 (Supplement 1): 3841.

https://doi.org/10.1182/blood-2018-99-111436

Published: 2018

Journal Articles

Loss of Abelson Interactor-1 Is Linked to Inflammatory Hematopoiesis and Accelerated Aging of Hematopoietic System

Anna Dorota Chorzalska, PhD, John Morgan, PhD, Max Petersen, Diana O Treaba, MD, Adam J Olszewski, MD, John L. Reagan, MD, Patrycja Dubielecka, PhD

Blood (2018) 132 (Supplement 1): 1285.

https://doi.org/10.1182/blood-2018-99-118393

Published: 2018

Journal Articles

Map3k8/COT1/Tpl2 Drives Resistance to Bcr-Abl1 Inhibition through Activation of MEK-ERK and NF-Kb Pathways

Anna Dorota Chorzalska, PhD, Nagib Ahsan, PhD, Alexander Tepper, Steven Hines, Diana Olguta Treaba, MD, Adam J Olszewski, MD, John L. Reagan, MD, Philip Gruppuso, MD, Patrycja Dubielecka, PhD

Blood (2017) 130 (Supplement 1): 2529.

https://doi.org/10.1182/blood.V130.Suppl_1.2529.2529

Published: 2017

Journal Articles

Beyond JAK-STAT: Contribution of Abi-1, STAT3, and NF-κB Signaling to Pathogenesis of Myeloproliferative Neoplasms

Anna Dorota Chorzalska, PhD, John Morgan, PhD, Diana Olguta Treaba, MD, Adam J Olszewski, MD, Kara Lombardo, Roberta Zini, BSc, PhD, Annalisa Pacilli, PhD, Alexander Tepper, John L. Reagan, MD, Leszek Kotula, MD, Peter J. Quesenberry, MD, Philip Gruppuso, MD, Rossella Manfredini, BSc, PhD, Alessandro M. Vannucchi, Patrycja Dubielecka, PhD

Blood (2017) 130 (Supplement 1): 4210.

https://doi.org/10.1182/blood.V130.Suppl_1.4210.4210

Published: 2017

Journal Articles

Bone Marrow-Specific Loss of ABI1 Induces Myelofibrosis through a Mechanism Involving Activation of NFκB

Blood (2016) 128 (22): 1203.

https://doi.org/10.1182/blood.V128.22.1203.1203

Published: 2016

NARROW

Recipients of Myelotoxic Chemotherapy Have Increased Prevalence of Clonal Hematopoiesis of Indeterminate Potential (CHIP) with a Typical Distribution of Chip-Associated Mutations

Loss of Abelson Interactor-1 Is Linked to Inflammatory Hematopoiesis and Accelerated Aging of Hematopoietic System

Map3k8/COT1/Tpl2 Drives Resistance to Bcr-Abl1 Inhibition through Activation of MEK-ERK and NF-Kb Pathways

Beyond JAK-STAT: Contribution of Abi-1, STAT3, and NF-κB Signaling to Pathogenesis of Myeloproliferative Neoplasms

Bone Marrow-Specific Loss of ABI1 Induces Myelofibrosis through a Mechanism Involving Activation of NFκB

Email alerts

ASH Publications

American Society of Hematology

Recipients of Myelotoxic Chemotherapy Have Increased Prevalence of Clonal Hematopoiesis of Indeterminate Potential (CHIP) with a Typical Distribution of Chip-Associated Mutations

Loss of Abelson Interactor-1 Is Linked to Inflammatory Hematopoiesis and Accelerated Aging of Hematopoietic System

Map3k8/COT1/Tpl2 Drives Resistance to Bcr-Abl1 Inhibition through Activation of MEK-ERK and NF-Kb Pathways

Beyond JAK-STAT: Contribution of Abi-1, STAT3, and NF-κB Signaling to Pathogenesis of Myeloproliferative Neoplasms

Bone Marrow-Specific Loss of ABI1 Induces Myelofibrosis through a Mechanism Involving Activation of NFκB

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only